Innosphere secured an equity investment for the purpose of achieving the FDA regulatory clearance


We are excited to announce that Innosphere has secured a significant equity investment to fund our upcoming clinical trials aimed at achieving FDA approval for our groundbreaking medical technology. With this investment, we can accelerate our efforts to bring our innovative product to market and make a positive impact on patients' lives. We are grateful for the confidence our investors have shown in our mission and look forward to updating the community on our progress.

x We use cookies to enhance the experience on our website. More about cookies.
✓ Accept